Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05458037 · ClinicalTrials.gov registry record · NA

RCT of Pain Perception With Fast and Slow Tenaculum Application

A NA study of Pain, Acute and Pain, Procedural, sponsored by Women and Infants Hospital of Rhode Island.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05458037: Recruiting NA study of Pain, Acute and Pain, Procedural, sponsored by Women and Infants Hospital of Rhode Island.

NCT05458037 is a NA study of Pain, Acute and Pain, Procedural that is actively recruiting participants, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 150 participants, above the 97-participant average among 31 other Pain, Acute trials with a reported enrollment target (55% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05458037, a NA study of Pain, Acute and Pain, Procedural, is actively recruiting participants, sponsored by Women and Infants Hospital of Rhode Island.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This project will be a randomized controlled trial (RCT) measuring pain perception with two different tenaculum placement techniques on the uterine cervix. A tenaculum is an instrument used to hold the cervix (the opening to the uterus or womb) in place. The trial will measure pain perception with a Visual Analog Scale (VAS) from 0 to 100 mm for two different tenaculum placement techniques, fast and slow closure on the uterine cervix. The main objective of this study is to determine if there is a difference in pain perception with fast compared to slow tenaculum placement techniques on the uterine cervix. We hypothesize that the slow technique will be perceived as less painful for subjects as measured on a 0 mm to 100 mm Visual Analog Scale (VAS). Subsidiary objectives include describing overall pain levels during the procedure.

Primary Outcome

Pain scores will be determined using the Visual Analog Scale (VAS) from 0 to 100 mm.

Interventions

  • PROCEDURE Speed of tenaculum application

Study Locations (1)

Rhode Island

  • Women and Infants Hospital - Providence

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2020-09-29
Est. Completion 2026-12
Phase NA

What NCT05458037 shows while recruiting

NCT05458037 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 97-participant average among 31 other Pain, Acute trials with a reported enrollment target (55% higher).

The record links to 2 conditions, with Pain, Acute appearing as the primary indexed condition, and to 1 intervention - of which Speed of tenaculum application is the first listed.

NCT05458037 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05458037 about?

NCT05458037 is a clinical study titled "RCT of Pain Perception With Fast and Slow Tenaculum Application". This project will be a randomized controlled trial (RCT) measuring pain perception with two different tenaculum placement techniques on the uterine cervix. A tenaculum is an instrument used to hold the cervix (the opening to the uterus or womb) in place. The trial will measure pain perception with a...

What is the current status of trial NCT05458037?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2020-09-29. Estimated completion is 2026-12.

What conditions does trial NCT05458037 study?

This clinical trial studies the following conditions: Pain, Acute, Pain, Procedural.

What interventions are being tested in trial NCT05458037?

The interventions under investigation include: Speed of tenaculum application (PROCEDURE).

Who is sponsoring clinical trial NCT05458037?

This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05458037 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05458037's enrollment target sits among peer trials

150 6th of 31 higher than 25 of 31 other Pain, Acute trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05458037, the US trial registry maintained by the National Library of Medicine. NCT05458037 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.